866-997-4948(US-Canada Toll Free)

Oryzon Genomics - Product Pipeline Analysis

Published By :

GlobalData

Published Date : Jun 2012

Category :

Surgical Equipment

No. of Pages : 29 Pages


Oryzon Genomics (Oryzon) is a biotechnology company, based in Spain. It develops diagnostic and therapeutic products for the healthcare markets. The company markets its products through its brands name GynEC DX, Cxbladder and ColoBRAF. Oryzons product GynEC DX is a new diagnostic test for Endometrial cancer that forms in the lining of the uterus. Its Cxbladder product is a non-invasive bladder cancer diagnostic test for lower abdomen. ColoBRAF is used for the treatment of colorectal cancer, which is common in industrialized countries. The company is certified as per ISO 9001 for quality system management. Oryzon is headquartered in Barcelona, Spain.

This report is a source for data, analysis and actionable intelligence on the Oryzon Genomics portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date.

Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalDatas team of industry experts.

Scope

  • Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments.
  • Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase.
  • Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date.
  • Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application.
  • Data on relevant clinical trials and product patent details, wherever applicable.
  • Information on clinical trial, wherever applicable, is supplemented with information on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility.

Reasons to Buy

  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape globally.
  • Design and develop your product development, marketing and sales strategies.
  • Exploit M&A opportunities by identifying market players with the most innovative pipeline.
  • Develop market-entry and market expansion strategies.
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
  • Develop competition strategies by identifying the status and likely launch of your competitors pipeline products through review of the clinical trials, stage and phase of development, etc.
  • Which are the next high-value products that your competitor would add in its portfolio? identify, understand and capitalize.
Table of Content

Table of Contents 2
List of Tables 3
List of Figures 4
Key Facts 5
Oryzon Genomics - Major Products and Services 6
Oryzon Genomics Pipeline Products by Equipment Type 7
Oryzon Genomics Pipeline Products by Development Stage 9
Oryzon Genomics Pipeline Products by Therapy Area 11
ColoBRAF 13
ColoBRAF Product Status 13
ColoBRAF Product Description 13
CX-BLADDER 14
CX-BLADDER Product Status 14
CX-BLADDER Product Description 14
Diagnostic Assay - Alzheimer\'s Disease 15
Diagnostic Assay - Alzheimer\'s Disease Product Status 15
Diagnostic Assay - Alzheimer\'s Disease Product Description 15
Diagnostic Assay - Alzheimer\'s Disease Product Patent Details 15
Diagnostic Assay - Huntington\'s Disease 17
Diagnostic Assay - Huntington\'s Disease Product Status 17
Diagnostic Assay - Huntington\'s Disease Product Description 17
Diagnostic Assay - Lung Cancer 18
Diagnostic Assay - Lung Cancer Product Status 18
Diagnostic Assay - Lung Cancer Product Description 18
Diagnostic Assay - Stomach Cancer 19
Diagnostic Assay - Stomach Cancer Product Status 19
Diagnostic Assay - Stomach Cancer Product Description 19
GynEC-DX 20
GynEC-DX Product Status 20
GynEC-DX Product Description 20
OG-px 21
OG-px Product Status 21
OG-px Product Description 21
Oryzon Diagnostic Test - Prostate Cancer 22
Oryzon Diagnostic Test - Prostate Cancer Product Status 22
Oryzon Diagnostic Test - Prostate Cancer Product Description 22
Prognostic Assay - Gastric Cancer 23
Prognostic Assay - Gastric Cancer Product Status 23
Prognostic Assay - Gastric Cancer Product Description 23
Prognostic Assay - GynEC-DX 24
Prognostic Assay - GynEC-DX Product Status 24
Prognostic Assay - GynEC-DX Product Description 24
Oryzon Genomics - Key Competitors 25
Oryzon Genomics - Key Employees 26
Oryzon Genomics - Locations And Subsidiaries 27
Head Office 27
Recent Developments 28
Oryzon Genomics, Recent Developments 28
Jan 10, 2011: ORYZON Wins $0.3 Million Research Grant To Develop New Therapeutics For Alzheimer\'s Disease 28

Appendix 29
Methodology 29
About GlobalData 29
Contact Us 29
Disclaimer 29

List of Table


Oryzon Genomics, Key Facts 1
Oryzon Genomics Key Pipeline Products by Equipment Type 1
Oryzon Genomics Key Pipeline Products by Therapy Area 1
Oryzon Genomics Key Pipeline Products by Development Stage 1
Oryzon Genomics, Key Facts 5
Oryzon Genomics, Major Products and Services 6
Oryzon Genomics Number of Pipeline Products by Equipment Type 7
Oryzon Genomics Pipeline Products by Equipment Type 8
Oryzon Genomics Number of Pipeline Products by Development Stage 9
Oryzon Genomics Pipeline Products by Development Stage 10
Oryzon Genomics Number of Pipeline Products by Therapy Area 11
Oryzon Genomics Pipeline Products by Therapy Area 12
ColoBRAF - Product Status 13
ColoBRAF - Product Description 13
CX-BLADDER - Product Status 14
CX-BLADDER - Product Description 14
Diagnostic Assay - Alzheimer\'s Disease - Product Status 15
Diagnostic Assay - Alzheimer\'s Disease - Product Description 15
Diagnostic Assay - Alzheimer\'s Disease - Patent Details 15
Diagnostic Assay - Huntington\'s Disease - Product Status 17
Diagnostic Assay - Huntington\'s Disease - Product Description 17
Diagnostic Assay - Lung Cancer - Product Status 18
Diagnostic Assay - Lung Cancer - Product Description 18
Diagnostic Assay - Stomach Cancer - Product Status 19
Diagnostic Assay - Stomach Cancer - Product Description 19
GynEC-DX - Product Status 20
GynEC-DX - Product Description 20
OG-px - Product Status 21
OG-px - Product Description 21
Oryzon Diagnostic Test - Prostate Cancer - Product Status 22
Oryzon Diagnostic Test - Prostate Cancer - Product Description 22
Prognostic Assay - Gastric Cancer - Product Status 23
Prognostic Assay - Gastric Cancer - Product Description 23
Prognostic Assay - GynEC-DX - Product Status 24
Prognostic Assay - GynEC-DX - Product Description 24
Oryzon Genomics, Key Employees 26

List of Chart

 
Oryzon Genomics Key Pipeline Products by Equipment Type 1
Oryzon Genomics Pipeline Products by Equipment Type 7
Oryzon Genomics Pipeline Products by Development Stage 9
Oryzon Genomics Pipeline Products by Therapy Area 11

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *